Precision medicine could transform the way Crohn’s disease and ulcerative colitis are treated - shifting the focus from symptom control to targeted, data-driven therapies designed for durable remission.
Advances in AI analytics, multiomic biomarker discovery, and patient-relevant models are accelerating smarter decision-making across IBD drug development.
Now in its fourth year, this summit brings together senior leaders in biopharma, translational research, and clinical development to explore how AI-enabled discovery, organoid and ex vivo models, and collaborative data strategies will redefine therapeutic success in IBD.
Download the agenda to see the sessions, speakers, and strategies driving the next generation of precision IBD therapies – and how innovation is translating into real-world impact for patients.
About Hanson Wade Group - 4th Precision Medicine in Inflammatory Bowel Disease Summit
Enhancing Biomarker Evaluation & Innovating Organoid & AI Models to Test & Validate Patient Samples to Improve Response Rate, Efficacy & Success of Inflammatory Bowel Disease Therapies
Precision medicine is transforming the future of Crohn’s disease and ulcerative colitis. With breakthroughs in AI-driven analytics, multiomic integration, and biomarker-guided therapy design, the field is finally moving beyond symptom management toward truly personalized, durable remission.
Now in its 4th year, the Precision Medicine in Inflammatory Bowel Disease Summit unites 50+ senior leaders across biopharma, translational science, and clinical development to accelerate the next generation of targeted IBD therapies.
This year’s agenda explores AI-enabled drug discovery, combination therapy design, organoid and ex vivo models, and collaborative data frameworks driving precision breakthroughs.
Join the leading minds shaping the next era of IBD treatment, where science, strategy, and innovation intersect to deliver smarter, faster, and more effective precision therapies for patients in need.
Download the Event Guide!
Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.net, which is to educate and inform site visitors interested in medical research, science, medical devices, and treatments.